53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
Hyfe pilot study tests a digital therapeutic combining passive cough monitoring with behavioral suppression techniques delivered through the CoughPro app.
This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.
Independent ERS 2025 NeuroCOUGH trial uses the Hyfe Cough Tracker to test feasibility of studying azithromycin's effect on cough and oesophageal motility.
Independent ERS 2025 trial uses the Hyfe Cough Tracker to show azithromycin reduces objective cough frequency by week one in chronic respiratory disease.
A triage tool that could identify patients who are most likely to have chest radiographic (CXR) abnormalities wouldimprove the efficiency of CXR utilization. Acoustic artificial intelligence techniques are being developed to extract diagnosticallyrelevant features from cough. Here we report the feasibility and preliminary performance of an AI-enabled cough classifier’s abilityto identify which patients are most likely to have abnormal CXRs based on cough sound.
